AposHealth

Company Overview

Snapshot

Founded in January 2004, AposHealth operates with 51–200 employees and has raised $37 million across 5 funding rounds from 5 investors. In February 2020, the company secured an $11 million Series A extension funding round.

Business overview

AposHealth develops solutions for identifying and treating gait-related conditions, focusing on improving movement and reducing pain. Its core product, the Apos3 device, is FDA-cleared for treating knee osteoarthritis, aiming to temporarily reduce knee pain and enhance lower extremity function. The company also offers AposIQ, a business unit that leverages innovative technology and data science to optimize gait adjustments for patients. AposHealth serves markets in the United Kingdom, United States, and Singapore, operating within the Health Tech & Life Sciences sector, specifically in digital healthcare, patient remote monitoring, medical devices, and medical treatment and therapeutics.

Strategic signal

In August 2020, Healthfirst New York formalized coverage of AposTherapy, an innovative therapy designed for orthopedic conditions. This development signals growing recognition and integration of AposHealth's solutions within established healthcare systems, potentially expanding patient access and validating the clinical efficacy of its gait modification technology for investors.

Company Intelligence Q&A

What was a key financial milestone for AposHealth in early 2020?

In February 2020, AposHealth announced an $11 million Series A extension funding round, led by existing shareholders including aMoon Fund.

What research was published in May 2020 regarding AposTherapy?

Research published in The Journal of the American Medical Association (JAMA) in May 2020 showed that knee osteoarthritis patients treated with AposTherapy experienced significant pain reduction.

Which organization formalized coverage for AposTherapy in New York?

In August 2020, Healthfirst New York formalized coverage of AposTherapy, an innovative therapy designed for orthopedic conditions.

With which physical therapy providers did AposTherapy partner in March 2020?

In March 2020, AposTherapy partnered with three physical therapy providers in Queens, New York, to offer its non-surgical solution for knee and lower back pain. The company also expanded its partnership with Professional Physical Therapy to additional Massachusetts locations in March 2020.

What was the focus of AposHealth's partnership with Spirit Access in May 2020?

In May 2020, Apos Medical Assets partnered with Spirit Access to decrease the cost of knee pain treatments in the UK.